[{"id":"f7315e28-fa58-4818-96a0-d6747f9a7418","acronym":"ISG-MCS","url":"https://clinicaltrials.gov/study/NCT04305548","created_at":"2022-03-10T21:59:21.461Z","updated_at":"2024-07-02T16:35:37.152Z","phase":"Phase 2","brief_title":"Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma","source_id_and_acronym":"NCT04305548 - ISG-MCS","lead_sponsor":"Italian Sarcoma Group","biomarkers":" HEY1 • NCOA2","pipe":"","alterations":" ","tags":["HEY1 • NCOA2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Yondelis (trabectedin)"],"overall_status":"Recruiting","enrollment":" Enrollment 16","initiation":"Initiation: 09/14/2021","start_date":" 09/14/2021","primary_txt":" Primary completion: 09/01/2024","primary_completion_date":" 09/01/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2023-09-13"}]